Search Results

Facet (Page)

Content Formats

31 - 40 of 51

Policy Issues

Revisions to the Common Rule modernize, simplify, and enhance oversight for human subjects research in the United States.

Policy Issues

Clinical research may yield new health-related information about volunteers who have chosen to participate in the studies.

Policy Issues

Scientific institutions are developing recommendations to support the responsible use of human gene-editing research.

Policy Issues

Patients with genetic disorders and members of the public have diverse about germline genome editing.

Policy Issues

Most ethical discussions about genome editing center on human germline editing because changes are passed down to future generations.

Policy Issues

Genome editing is currently being applied to research on cancer, mental health, rare diseases, and many other disease areas.

Policy Issues

Scientists have edited genomes for many years, but CRISPR technology has improved the speed, cost, accuracy, and efficiency of genome editing

Policy Issues

Genome editing is a method that lets scientists change the DNA of many organisms, including plants, bacteria, and animals.

Policy Issues

Synthetic biology is a field of science that involves redesigning organisms for useful purposes by engineering them to have new abilities.

Policy Issues

Payers such as insurance companies and Medicare need systematic ways of evaluating genetic tests for reimbursement.